Published in Cancer Weekly, January 29th, 2008
"This collaboration offers Morphotek novel technology and model systems to rapidly validate targets and potential therapeutic lead antibodies generated from our MORPHODOMA(R)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.